Project Scope | |
The scope for the project covers twin objectives:
|
| Sub Teams |
|---|
1. Pilot Submissions Report
2. Business Case
3. Technical Implementation
4. Strategy for Future Development
|
| Project Impact |
|---|
The XPT file format is outdated and imposes limitations on submission data due to the lack of modern features – for example, XPT files are limited to US ASCII Character encoding, have restricted variable names/sizes, inefficient use of storage space, use a non-extensible tabular structure and lack any integrated metadata. The impact of overcoming these limitations will be seen initially by regulators; however, by far the bigger impact will be seen in the medium to longer term, where, by lifting the restrictions of XPT, and moving to Dataset-JSON, new standards will be able to take advantage of these enhanced capabilities, and drive efficiencies, consistency and re-usability across the clinical research data life cycle. |
| Project Leads | ||
|---|---|---|
Sam Hume, CDISC | ||
Stuart Malcolm, Veramed | ||
Jesse Anderson, FDA | Nicola Newton, PHUSE Project Assistant |
| Q1 2025 | ||||||
|---|---|---|---|---|---|---|---|
|
Objectives & Deliverables | Timelines |
|---|---|
PHUSE Team formation Engaged with collaboration partners (CDSIC, FDA etc.) | Q2 2023 |
Initial technical/ regulatory deliverables CSS workshop – Workstream roundtable | Q3 2023 |
| Industry deliverables (PHUSE EU Connect) | Q4 2023 |
| Standards deliverables | Q1 2024 |
All project deliverables published CSS workshops – Project findings and recommendations | Q2 2024 |
| Resources |
|---|
| Summary of the pilot findings to date and recommended solutions |
| Pilot participation testing and reporting instructions |
| SBIA webinar: Dataset-JSON Pilot Report and Next Steps |
Dataset-JSON Webinar Please find the recording and presentations from the Webinar that took place on 1 February. | |
|---|---|
Introduction, presented by Stuart Malcom, Veramed | |
| Pilot Submissions Status Update, presented by Sam Hume, CDISC | |
| Technical Implementation Topics, presented by Jesse Anderson, FDA | |
| Business Case, presented by Marguerite Kolb, Johnson & Johnson | |
| Strategy for Future Development, presented by Nicole Thorne, BMS | |

.jpg?version=1&modificationDate=1734524860028&cacheVersion=1&api=v2)